These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Pharmacokinetics of carvedilol in older and younger patients. Morgan T; Anderson A; Cripps J; Adam W J Hum Hypertens; 1990 Dec; 4(6):709-15. PubMed ID: 2096213 [TBL] [Abstract][Full Text] [Related]
26. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial. Erdoğan O; Ertem B; Altun A Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293 [TBL] [Abstract][Full Text] [Related]
27. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients. Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377 [TBL] [Abstract][Full Text] [Related]
28. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904 [TBL] [Abstract][Full Text] [Related]
29. [A comparison of the effect of oral captopril and nicardipine in hypertensive crisis]. Addad F; Ferjani H; Chaabani A; Jelliti M; Gamra H; Makni H; Khaldoun BH; Dridi Z; Ben Farhat M Tunis Med; 2008 Feb; 86(2):150-4. PubMed ID: 18444532 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension. Weber MA; Bakris GL; Tarka EA; Iyengar M; Fleck R; Sica DA J Clin Hypertens (Greenwich); 2006 Dec; 8(12):840-9. PubMed ID: 17170609 [TBL] [Abstract][Full Text] [Related]
31. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group. Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462 [TBL] [Abstract][Full Text] [Related]
33. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension]. Perocchio M; Gigli G; Barra M; Sacchetti R; Vallebona A; Rosolen GA; Orlandi S Minerva Cardioangiol; 1996 Mar; 44(3):115-21. PubMed ID: 8767610 [TBL] [Abstract][Full Text] [Related]
34. Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study. Ayashi S; Assareh AR; Jalali MT; Olapour S; Yaghooti H Indian J Pharmacol; 2016; 48(4):372-376. PubMed ID: 27756946 [TBL] [Abstract][Full Text] [Related]
35. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. Kalay N; Basar E; Ozdogru I; Er O; Cetinkaya Y; Dogan A; Inanc T; Oguzhan A; Eryol NK; Topsakal R; Ergin A J Am Coll Cardiol; 2006 Dec; 48(11):2258-62. PubMed ID: 17161256 [TBL] [Abstract][Full Text] [Related]
36. Response rate with respect to the blood pressure-lowering effect of the vasodilating and beta-blocking agent carvedilol. Rittinghausen R Drugs; 1988; 36 Suppl 6():92-101. PubMed ID: 2908307 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol. Marchi F; Ciriello G Adv Ther; 1995; 12(4):212-21. PubMed ID: 10155349 [TBL] [Abstract][Full Text] [Related]
38. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy]. Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367 [TBL] [Abstract][Full Text] [Related]
39. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol. Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088 [TBL] [Abstract][Full Text] [Related]
40. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution. Rusconi P; Gómez-Marín O; Rossique-González M; Redha E; Marín JR; Lon-Young M; Wolff GS J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]